Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury

[Image: see text] Tolvaptan is an effective drug for the treatment of autosomal dominant polycystic kidney disease, but its use is associated with a significant risk of liver injury in a small number of patients. Herein we describe the presence of tolvaptan- and tolvaptan-metabolite-responsive T cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Andrew, Hammond, Sean, Jaruthamsophon, Kanoot, Roth, Sharin, Mosedale, Merrie, Naisbitt, Dean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672698/
https://www.ncbi.nlm.nih.gov/pubmed/33085478
http://dx.doi.org/10.1021/acs.chemrestox.0c00328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672698/
https://www.ncbi.nlm.nih.gov/pubmed/33085478
http://dx.doi.org/10.1021/acs.chemrestox.0c00328

Ejemplares similares